PALISADE BIO INC (PALI) Stock Balance Sheet
NASDAQ:PALI - Nasdaq - US6963894026 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.04M | 12.43M | 12.38M | 10.49M | 10.53M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 96.00K | 148.00K | 1.44M | 150.00K | 116.00K | |||
| Other Current Assets | 734.00K | 748.00K | 912.00K | 861.00K | 2.23M | |||
| Total Current Assets | 8.87M | 13.33M | 14.73M | 11.51M | 12.88M | |||
| Non-Current Assets | ||||||||
| PPE Net | 116.00K | 208.00K | 310.00K | 112.00K | 11.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | 147.00K | |||
| Other Non-Current Assets | 350.00K | 516.00K | 720.00K | 894.00K | 10.00K | |||
| Total Non-Current Assets | 466.00K | 724.00K | 1.03M | 1.01M | 168.00K | |||
| TOTAL ASSETS | 9.34M | 14.05M | 15.76M | 12.51M | 13.05M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 235.00K | 158.00K | 88.00K | 87.00K | N/A | |||
| Accrued Expenses | 2.08M | 1.73M | 1.17M | 1.09M | 2.32M | |||
| Accounts Payable | 366.00K | 698.00K | 1.76M | 1.32M | 649.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 234.00K | |||
| Total Current Liabilities | 2.68M | 2.59M | 3.01M | 2.50M | 3.21M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 47.00K | 153.00K | 272.00K | 2.65M | 75.00K | |||
| Total Non-Current Liabilities | 47.00K | 153.00K | 272.00K | 2.65M | 75.00K | |||
| TOTAL LIABILITIES | 2.73M | 2.74M | 3.28M | 5.15M | 3.28M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -132.60M | -121.51M | -109.19M | -94.64M | -238.24M | |||
| Additional Paid In Capital | 139.19M | 132.72M | 121.64M | 102.00M | 247.84M | |||
| Common Shares | 13.00K | 95.00K | 32.00K | 5.00K | 175.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | -1.00K | |||
| Shares Outstanding | 1.20M | 618.00K | 196.00K | 19.00K | 4.00K | |||
| Tangible Book Value per Share | 5.51 | 18.30 | 63.66 | 387.53 | 2.40K | |||
| Total Shareholders' Equity | 6.61M | 11.31M | 12.48M | 7.37M | 9.77M | |||
| TOTAL LIABILITIES AND EQUITY | 9.34M | 14.05M | 15.76M | 12.51M | 13.05M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.31 | 5.15 | 4.89 | 4.61 | 4.02 | |||
| Return On Assets (ROA) | -150.65% | -87.53% | -90.47% | -212.72% | -124.66% | |||
| Return On Equity (ROE) | -212.85% | -108.72% | -114.27% | -361.38% | -166.53% | |||
All data in USD , ROIC based on taxRate of 0.21